The incidence of vascular events in HIV-infected individuals is increasing. We investigated
whether there is a higher prevalence of vascular risk factors in the adult US population with …

Background. Cardiovascular disease (CVD) has become more prominent among human
immunodeficiency virus (HIV)–infected individuals. The extent to which CVD mortality rates …

Background. There is concern that human immunodeficiency virus (HIV) infection and the
use of highly active antiretroviral therapy lead to accelerated atherosclerosis and increased …

Coomprhensive data on temporal trends in cardiovascular disease (CVD) risk factors and
outcomes in people living with HIV are limited. Using retrospective data on 50,284 US …

Background: As a result of effective antiretroviral therapy HIV patients are living longer, and
their risk of cardiovascular disease (CVD) is a growing concern. It remains unknown whether …

With aging of the HIV-infected population, non-AIDS conditions such as cardiovascular
disease (CVD) now account for substantial mortality and morbidity. While myocardial …

Objective Due to side effects, such as hyperlipidaemia and insulin resistance, there is an
increasing concern that antiretroviral drugs lead to an epidemic of cardiovascular diseases …

With more effective and widespread antiretroviral treatment, the overall incidence of AIDS-or
HIV-related death has decreased dramatically. Consequently, as patients are aging …

Cardiovascular disease (CVD) related to HIV infection is becoming a major public health
concern in the United Stated. Epidemiologic studies show that prolonged use of Highly …

Background Human immunodeficiency virus (HIV) may affect the risk of death due to
cardiovascular disease (CVD) differently in men versus women. Methods We examined …